SIBO and Flatulence: When Bacteria Grow in the Wrong Place
Small Intestinal Bacterial Overgrowth (SIBO) is one of the most misunderstood and underdiagnosed causes of chronic bloating and excessive flatulence. When bacteria that normally inhabit the large intestine colonize the small intestine, the digestive consequences are significant — and frequently misattributed to irritable bowel syndrome or food intolerance.
What Is SIBO? Bacteria in the Wrong Place
The small intestine is a relatively bacteria-sparse environment. In healthy adults it contains roughly 10³–10⁵ bacteria per milliliter of intestinal fluid, compared to 10¹¹–10¹² per milliliter in the large intestine. Several protective mechanisms maintain this low count: stomach acid destroys most incoming bacteria; bile and pancreatic enzymes have bactericidal properties; intestinal motility (the migrating motor complex) flushes bacteria downward between meals; and the ileocecal valve acts as a physical barrier preventing large-intestinal bacteria from migrating upward. When any of these mechanisms breaks down, bacteria from the colon can colonize the small intestine in abnormal numbers. SIBO is clinically defined as more than 10⁵ colony-forming units per milliliter of proximal small-bowel aspirate. The clinical spectrum is wide: from mild intermittent bloating to severe malabsorption with weight loss and deficiencies in vitamins B12, D, and fat-soluble nutrients. Estimates suggest SIBO affects 6–15% of healthy adults and 30–85% of patients diagnosed with irritable bowel syndrome, indicating massive underdiagnosis in the general population.
Why SIBO Causes Excessive Gas
The link between SIBO and flatulence is direct and mechanical. In a healthy gut, dietary carbohydrates are efficiently absorbed in the small intestine before they reach the bacteria-rich colon. With SIBO, bacteria in the small intestine encounter these carbohydrates prematurely and begin fermenting them on the spot, producing abnormally large volumes of hydrogen, methane, and carbon dioxide in a location not designed to handle such volumes. The result is rapid, severe bloating and abdominal distension appearing 15–60 minutes after eating — far earlier than symptoms from normal colonic fermentation. Hydrogen-dominant SIBO typically causes diarrhea because hydrogen accelerates intestinal transit. Methane-dominant SIBO — now often classified as Intestinal Methanogen Overgrowth (IMO) — causes constipation because methane directly slows gut motility. A third variant, hydrogen sulfide-dominant SIBO, is notorious for producing particularly foul-smelling gas.
Diagnosis: The Hydrogen Breath Test
The hydrogen breath test offers a non-invasive alternative to endoscopy that has become standard in gastroenterology. The patient fasts overnight, drinks a sugar solution — typically glucose or lactulose — then exhales into collection bags at regular intervals over two to three hours. If bacteria in the small intestine ferment the sugar, the resulting hydrogen or methane is absorbed through the intestinal wall into the bloodstream and exhaled through the lungs, creating an abnormally early peak in breath gas concentration. A rise of 20 or more parts per million of hydrogen within 90 minutes is considered diagnostic for SIBO by most international guidelines. The glucose test has higher specificity but only detects proximal SIBO; the lactulose test covers a broader range but produces more false positives. Methane measurement, now routinely included in modern breath-testing kits, allows identification of the methane-producing variant.
Treatment and the Recurrence Problem
Standard first-line treatment for SIBO is antibiotic therapy, most commonly rifaximin — a non-absorbable antibiotic that acts exclusively within the intestinal lumen without entering systemic circulation. Rifaximin achieves symptomatic remission in approximately 60–80% of cases. For methane-dominant SIBO, combining rifaximin with a second antibiotic (typically neomycin or metronidazole) yields significantly better results. The key challenge is recurrence: without treating the underlying mechanism, recurrence rates reach 40–50% within nine months of successful treatment. Predisposing conditions include hypochlorhydria (frequently caused by proton-pump inhibitor use), impaired gut motility, anatomical abnormalities such as strictures or diverticula, and immune deficiencies. The low-FODMAP diet can substantially reduce symptoms without eliminating the overgrowth itself. The role of probiotics in SIBO remains controversial: some evidence suggests lactobacillus-rich probiotics can worsen hydrogen-dominant SIBO by increasing fermentation load in an already overloaded environment.
Did You Know?
- SIBO is defined as more than 10⁵ bacteria per milliliter of small-intestinal fluid — the colon has 10¹¹, while the small intestine should have far fewer.
- The hydrogen breath test diagnoses SIBO non-invasively: bacteria produce hydrogen that travels to the lungs and is exhaled.
- Methane-dominant SIBO (also called IMO) causes constipation because methane directly slows intestinal motility.
- Rifaximin, the primary antibiotic for SIBO, is non-absorbable — it targets bacteria in the intestinal lumen without entering the bloodstream.
Fun Fact
The term SIBO only entered medical mainstream around 2000, although the condition was described as early as 1966 by Donaldson observing patients with blind loop syndrome — caused by surgical bypass anastomoses creating stagnant intestinal segments where bacteria could proliferate unchecked. The modern hydrogen breath test allows a definitive diagnosis in a single outpatient visit instead of surgery.
Sources
- Ghoshal, U.C. et al. (2017). Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome. Journal of Gastroenterology and Hepatology.
- Pimentel, M. (2016). Evidence-based management of irritable bowel syndrome with bacterial overgrowth. American Journal of Gastroenterology.
- Rezaie, A. et al. (2017). Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders. American Journal of Gastroenterology.